Polydex Pharmaceuticals - Delisted Pink Sheet
Polydex Pharmaceuticals is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Polydex Pharmaceuticals was actively traded.
Valuation
Check how we calculate scores
Polydex Pharmaceuticals Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Polydex Pharmaceuticals market risk premium is the additional return an investor will receive from holding Polydex Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Polydex Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Polydex Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Polydex Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 1.17 | |||
Semi Deviation | 1.65 | |||
Standard Deviation | 2.22 | |||
Variance | 4.91 |
Polydex Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Polydex Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Polydex Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Polydex Pharmaceuticals by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Polydex Pharmaceuticals Corporate Executives
Elected by the shareholders, the Polydex Pharmaceuticals' board of directors comprises two types of representatives: Polydex Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Polydex. The board's role is to monitor Polydex Pharmaceuticals' management team and ensure that shareholders' interests are well served. Polydex Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Polydex Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
John Luce | CFO and Principal Accounting Officer | Profile | |
Sharon Wardlaw | COO, Secretary, Treasurer and Pres Dextran Products Limited | Profile |
Still Interested in Polydex Pharmaceuticals?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Polydex Pink Sheet
If you are still planning to invest in Polydex Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Polydex Pharmaceuticals' history and understand the potential risks before investing.
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Transaction History View history of all your transactions and understand their impact on performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |